Trial intelligence / Profile preview

Maraviroc and Raltegravir Interaction Study

NCT00666705Phase 4Completed

Sponsor
ViiV Healthcare
Start
Feb 2008
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Feb 2008; status: completed.

02

Drugs

maraviroc
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00666705.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00666705.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call